How HIV Research Has Reshaped Modern Medicine
With some 1.3 million new infections a year, a vaccine remains the best way to end the HIV epidemic, said Dan Barouch, the William Bosworth Castle Professor of Medicine at HMS and director […]
This author has not written his bio yet.
But we are proud to say that Sesedzayi Persesuh contributed 45 entries already.
With some 1.3 million new infections a year, a vaccine remains the best way to end the HIV epidemic, said Dan Barouch, the William Bosworth Castle Professor of Medicine at HMS and director […]
The Boston area is home to a critical mass of leading universities, hospitals, biotechnology and pharmaceutical companies, and independent research institutions that all interact synergistically, says Dan Barouch, an immunologist […]
HMS professor and immunologist Dan H. Barouch ’93, who was not affiliated with the study, said its results could be applied to various respiratory illnesses, beyond those tested during experiments. […]
Barouch and colleagues assessed mpox-specific immune responses for 12 months in 45 individuals who were vaccinated during the 2022 mpox outbreak. The team performed an observational study in adults who […]
“The WHO declared the current mpox outbreak in the Democratic Republic of the Congo a public health emergency,” said corresponding author Dan H. Barouch, MD, Ph.D., director of the Center for […]
“Our data shows that the antibody responses induced by the mpox vaccine are moderate to high titer after the two-dose vaccine,” said Dr. Dan Barouch, lead author of the study […]
“Overall, our study showed that three anti-HIV antibodies with significant breadth of neutralization were actually able to maintain virological suppression in the absence of ART at least during the dosing […]
But the new data may not reflect the current climate, said Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, who […]
Dr. Dan Barouch, a Harvard Medical School virologist, said it was likely the U.S. would see clade I cases. “The absolute risk in the U.S. is currently low,” he said. […]
The finding of lenacapavir having 100% efficacy for HIV prevention in women “is an important advance for the field, and I think that the field will welcome it as an […]
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu